证券记录 · 已归档季度
PCVX
Vaxcyte, Inc. · Healthcare · Biotechnology
10被追踪持有人
+2Δ持有人
13.93M持有股份
$1.59B报告持仓市值
+3新建仓位
−1清仓
动量输入（同类管理人）：
持有人广度 +25.0% ·
股份流向 +18.9% ·
净新建仓位 +20.0%
— 公式
广泛积累 — 持股数量上升且持有人增多
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q3 2024
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q2 2026 | 114 | +1 | 85.77M | $4.99B | +6 | −4 |
| Q1 2026 | 115 | +4 | 93.55M | $5.43B | +8 | −5 |
| Q4 2025 | 111 | 0 | 92.90M | $4.29B | +2 | −1 |
| Q3 2025 | 18 | +2 | 60.74M | $2.19B | +3 | −2 |
| Q2 2025 | 14 | 0 | 57.50M | $1.87B | +1 | −1 |
| Q1 2025 | 11 | -1 | 19.96M | $753.77M | — | −1 |
| Q4 2024 | 12 | +1 | 18.46M | $1.51B | +1 | — |
| Q3 2024 | 10 | +2 | 13.93M | $1.59B | +3 | −1 |
| Q2 2024 | 8 | — | 11.72M | $885.19M | — | — |
持有人 · Q3 2024
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Wellington Management ✦ | 4.51M | -1.7% | $515.79M | 0.1% | ▼ Trim | 2 | SEC ↗ |
| 2 | Wellington Management ✦ | 4.51M | -1.7% | $515.79M | 0.1% | ▼ Trim | 2 | SEC ↗ |
| 3 | Wellington Management ✦ | 4.51M | -1.7% | $515.79M | 0.1% | ▼ Trim | 2 | SEC ↗ |
| 4 | Wellington Management ✦ | 4.51M | -1.7% | $515.79M | 0.1% | ▼ Trim | 2 | SEC ↗ |
| 5 | Wellington Management ✦ | 4.51M | -1.7% | $515.79M | 0.1% | ▼ Trim | 2 | SEC ↗ |
| 6 | Wellington Management ✦ | 4.51M | -1.7% | $515.79M | 0.1% | ▼ Trim | 2 | SEC ↗ |
| 7 | Wellington Management ✦ | 4.51M | -1.7% | $515.79M | 0.1% | ▼ Trim | 2 | SEC ↗ |
| 8 | Wellington Management ✦ | 4.51M | -1.7% | $515.79M | 0.1% | ▼ Trim | 2 | SEC ↗ |
| 9 | T. Rowe Price ✦ | 4.47M | +40.8% | $510.35M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 10 | T. Rowe Price ✦ | 4.47M | +40.8% | $510.35M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 11 | Geode Capital Management ✦ (被动) | 2.70M | +10.6% | $308.67M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 12 | Geode Capital Management ✦ (被动) | 2.70M | +10.6% | $308.67M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 13 | Norges Bank ✦ (被动) | 1.11M | +13.0% | $127.13M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 14 | D. E. Shaw & Co. ✦ | 423.50K | +84.0% | $48.39M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 15 | Point72 Asset Management ✦ | 359.80K | 新增 | $41.11M | 0.1% | New | 1 | SEC ↗ |
| 16 | Millennium Management ✦ | 298.44K | +46.5% | $34.10M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 17 | Duquesne Family Office ✦ | 42.97K | 新增 | $4.91M | 0.2% | New | 1 | SEC ↗ |
| 18 | AQR Capital Management ✦ | 11.11K | +2.3% | $1.27M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 19 | AQR Capital Management ✦ | 11.11K | +2.3% | $1.27M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 20 | Citadel Advisors ✦ | 5.87K | 新增 | $670,422 | 0.0% | New | 1 | SEC ↗ |
| 21 | Citadel Advisors ✦ | 5.87K | 新增 | $670,422 | 0.0% | New | 1 | SEC ↗ |
"持仓权重"= 该持仓占该管理人已申报13F股权价值的比例——即信念度衡量指标。✦ = 精选管理人。
新增买入方
| Point72 Asset Management | $41.11M | 0.1% |
| Duquesne Family Office | $4.91M | 0.2% |
| Citadel Advisors | $670,422 | 0.0% |
| Citadel Advisors | $670,422 | 0.0% |
已清仓
| Adage Capital Partners | $6.42M | 曾为 0.0% |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 1 持有人, 53.30K 股份, $3,097 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
常见共同持仓
该证券的被追踪持有人最常同时持有的其他证券——基于共同持有计数，而非基本面关联。
数据来源: 持股数据来源于已解析的13F普通股持仓（被追踪范围，变动对比集）；内部人行为来自Form 3/4/5；重大持股来自Schedule 13D/13G；所有文件均链接至SEC EDGAR原始申报。
报告期: Q3 2024 ·
方法论 ·
通过API获取此数据